Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Frontiers in Oncology
|
September 26, 2025
Integrating single-cell omics and materials science for uveal melanoma: from mechanistic insights to precision therapeutics
Shouyong Fu, Changfei Li
Frontiers in Physiology
|
April 28, 2025
Overview of detection methods of fetomaternal haemorrhage
Xinyang Li, Changfei Li, Tiemei Liu
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|
October 8, 2021
[Research progress of AFP in the diagnosis and therapy of hepatocellular carcinoma]
Liyuan Qian, Changfei Li, Yunjing Luo, et al.
Wei Sheng Wu Xue Bao = Acta Microbiologica Sinica
|
December 30, 2015
[PTTG1 enhances Hepatitis B Virus replication through P53]
Shanxin Peng, Changfei Li, Lu Sun, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|
November 9, 2020
[Research progress on Toll-like receptors pathways regulating function of regulatory T cells]
Peng Guo, Han Zhang, Changfei Li, et al.
Wei Sheng Wu Xue Bao = Acta Microbiologica Sinica
|
March 26, 2015
[NF-kappaB-induced gp96 up-regulation promotes hepatocyte growth, cell cycle progression and transition]
Cong Feng, Bo Wu, Hongxia Fan, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|
September 24, 2022
[PEGylation effectively improves anti-breast cancer efficiency of heat shock protein gp96 inhibitory polypeptide]
Lulu Liu, Jianwei Gao, Changfei Li, et al.
Journal of Clinical Medicine
|
October 14, 2022
To Achieve a Bullseye: Factors Related to Corneal Refractive Therapy Orthokeratology Lens Toricity
Changfei Li, Li Zeng, Jiaqi Zhou, et al.
International Journal of Cancer
|
January 12, 2010
RNAi-mediated downregulation of uPAR synergizes with targeting of HER2 through the ERK pathway in breast cancer cells
Changfei Li, Sheng Cao, Zhen Liu, et al.
Oncotarget
|
November 29, 2017
Urokinase-type plasminogen activator receptor inhibits apoptosis in triple-negative breast cancer through miR-17/20a suppression of death receptors 4 and 5
Xin Li, Bo Wu, Lizhao Chen, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Frontiers in Oncology
|
September 26, 2025
Integrating single-cell omics and materials science for uveal melanoma: from mechanistic insights to precision therapeutics
Shouyong Fu, Changfei Li
Frontiers in Physiology
|
April 28, 2025
Overview of detection methods of fetomaternal haemorrhage
Xinyang Li, Changfei Li, Tiemei Liu
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|
October 8, 2021
[Research progress of AFP in the diagnosis and therapy of hepatocellular carcinoma]
Liyuan Qian, Changfei Li, Yunjing Luo, et al.
Wei Sheng Wu Xue Bao = Acta Microbiologica Sinica
|
December 30, 2015
[PTTG1 enhances Hepatitis B Virus replication through P53]
Shanxin Peng, Changfei Li, Lu Sun, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|
November 9, 2020
[Research progress on Toll-like receptors pathways regulating function of regulatory T cells]
Peng Guo, Han Zhang, Changfei Li, et al.
Wei Sheng Wu Xue Bao = Acta Microbiologica Sinica
|
March 26, 2015
[NF-kappaB-induced gp96 up-regulation promotes hepatocyte growth, cell cycle progression and transition]
Cong Feng, Bo Wu, Hongxia Fan, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|
September 24, 2022
[PEGylation effectively improves anti-breast cancer efficiency of heat shock protein gp96 inhibitory polypeptide]
Lulu Liu, Jianwei Gao, Changfei Li, et al.
Journal of Clinical Medicine
|
October 14, 2022
To Achieve a Bullseye: Factors Related to Corneal Refractive Therapy Orthokeratology Lens Toricity
Changfei Li, Li Zeng, Jiaqi Zhou, et al.
International Journal of Cancer
|
January 12, 2010
RNAi-mediated downregulation of uPAR synergizes with targeting of HER2 through the ERK pathway in breast cancer cells
Changfei Li, Sheng Cao, Zhen Liu, et al.
Oncotarget
|
November 29, 2017
Urokinase-type plasminogen activator receptor inhibits apoptosis in triple-negative breast cancer through miR-17/20a suppression of death receptors 4 and 5
Xin Li, Bo Wu, Lizhao Chen, et al.
Page
of 5